First developed more than four decades ago as a biological research technique to amplify nucleic acids, polymerase chain reaction (PCR) technology still has untapped potential, with many exciting ...

Inecalcitol is a vitamin D receptor agonist currently in Phase II clinical trial in AML (acute myeloid leukemia). Inecalcitol increases the expression ... This platform also provides significant cost ...

The presence of BCR-ABL1 is associated with several types of leukemia — mainly CML but also ALL and AML less commonly. Several tests, including cytogenetics, FISH, and PCR, can be used to detect ...

that often go undetected by previous generations of PCR-based enrichment technologies. The ultra-sensitive detection of MRD in AML is a critical tool for advancing clinical research in AML.